Page last updated: 2024-09-02

kt 5823 and Breast Cancer

kt 5823 has been researched along with Breast Cancer in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Beyer, S; Jhiang, S; Lakshmanan, A; Liu, YY; Smolenski, A; Wapnir, I; Zhang, X	1

Other Studies

1 other study(ies) available for kt 5823 and Breast Cancer

Article	Year
KT5823 differentially modulates sodium iodide symporter expression, activity, and glycosylation between thyroid and breast cancer cells. Endocrinology, 2011, Volume: 152, Issue:3 Topics: Animals; Breast Neoplasms; Brefeldin A; Carbazoles; Cell Line; Female; Gene Expression Regulation, Neoplastic; Glycosylation; Humans; Hydrocortisone; Iodides; Protein Kinase Inhibitors; Protein Synthesis Inhibitors; Rats; Symporters; Thyroid Gland; Thyrotropin; Tretinoin	2011

Article

Year

KT5823 differentially modulates sodium iodide symporter expression, activity, and glycosylation between thyroid and breast cancer cells.

Endocrinology, 2011, Volume: 152, Issue:3

Topics: Animals; Breast Neoplasms; Brefeldin A; Carbazoles; Cell Line; Female; Gene Expression Regulation, Neoplastic; Glycosylation; Humans; Hydrocortisone; Iodides; Protein Kinase Inhibitors; Protein Synthesis Inhibitors; Rats; Symporters; Thyroid Gland; Thyrotropin; Tretinoin

2011